Greek businessman Dimitris Giannakopoulos is rather well-known. Known for owning Panathinaikos BC and serving as CEO of Vianex S.A., Greece’s leading pharmaceutical company, as of 2024 his projected net worth is $1.9 billion.
| Category | Details |
|---|---|
| Full Name | Dimitris Giannakopoulos |
| Date of Birth | June 22, 1974 |
| Net Worth | $1.9 billion (2024) |
| Occupation | CEO of Vianex S.A., Owner of Panathinaikos BC |
| Nationality | Greek |
| Children | 2 |
Following the resignation of his father, Pavlos Giannakopoulos, Giannakopoulos took over Vianex in 2012. Since then, the company has grown and teamed with multinational pharmaceutical behemoths to manufacture and distribute drugs all around.
One of Greece’s best basketball teams, Panathinaikos BC, is under ownership by him Under Giannakopoulos, Panathinaikos has stayed competitive in the EuroLeague and has won multiple Greek titles. His approach of management has been distinguished by passion and controversy.
Bold choices made by Giannakopoulos are well-known. Claiming dissatisfaction with EuroLeague management and financial constraints, he offered to sell Panathinaikos for €25 million in 2020. He still is dedicated to the success of the club nonetheless.
| Business Ventures | Contribution to Net Worth |
|---|---|
| Vianex S.A. | 80% |
| Panathinaikos BC | 15% |
| Superfoods S.A. | 5% |
Most of Giannakopoulos’s income comes from his main commercial endeavour, Vianex. The corporation produces and markets prescription drugs both here at home and abroad. Among its most noteworthy successes is its cooperation with Eli Lilly for the Chinese market.
His riches also stem from his ownership in Greek health and supplement firm Superfoods S.A. In 2016 he bought half of the company, therefore diversifying his portfolio and supporting his continued participation in the health industry.
Giannakopoulos’s business leadership transcends Vianex. His participation with Superfoods has enabled the brand to be more visible in the natural health sector. His approaches to investing have kept him leading edge in Greek industry.
Giannakopoulos has had issues notwithstanding his business success. Especially in the EuroLeague, his aggressive approach in sports management has resulted in fines and public conflicts. Still, he is a key player in Greek sports and business.
Leading the Pavlos Giannakopoulos Foundation, honoring his late father, are part of his charitable activities. Foundation supports environmental initiatives, education, and healthcare. Returning to the Greek community excites Giannakopoulos.
Greece’s economic situation has impacted his firm, but his varied investments—especially in pharmaceuticals—have helped him to ride out financial storms. His companies have been expanding since he can adapt and be creative.
Giannakopoulos has set Vianex’s succession policies, therefore guaranteeing the company’s future. In the next years, his offspring are supposed to inherit the family legacy in Greek industry and beyond.
FAQs:
1. What is Dimitris Giannakopoulos’s net worth?
His net worth is estimated at $1.9 billion as of 2024.
2. What businesses does Giannakopoulos own?
He owns Vianex S.A., Greece’s largest pharmaceutical company, and Panathinaikos BC. He also holds a 50% stake in Superfoods S.A.
3. What controversies has Giannakopoulos been involved in?
He has faced several controversies, particularly in his role as Panathinaikos owner, including disputes with EuroLeague officials.
